Resources

Resources

Maintaining Patient, Provider, and Product Continuity at Commercial Launch

A leading orphan and rare disease product manufacturer was approaching a key inflection point in the evolution of its industry-leading intravenously (IV) administered product and faced a near-term need to launch a subcutaneous (SC) formulation to meet an identified unmet patient need and respond to its first competitor product launching across multiple indications and therapy areas. Read more about how they were able to solve the problem in this case study.

Download now!

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand